| Product Code: ETC6366514 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Belgium saw a significant increase in vaccine contract manufacturing import shipments, with the USA, Austria, Netherlands, Hungary, and the UK emerging as the top exporting countries. Despite high concentration levels measured by the HHI index, the industry experienced a remarkable compound annual growth rate (CAGR) of 39.8% from 2020 to 2024. However, there was a notable decline in the growth rate from 2023 to 2024, showing a decrease of -59.2%. These trends indicate both opportunities and challenges for Belgium`s vaccine manufacturing sector in the coming years.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Vaccine Contract Manufacturing Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Vaccine Contract Manufacturing Market Revenues & Volume, 2022 & 2032F |
3.3 Belgium Vaccine Contract Manufacturing Market - Industry Life Cycle |
3.4 Belgium Vaccine Contract Manufacturing Market - Porter's Five Forces |
3.5 Belgium Vaccine Contract Manufacturing Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Belgium Vaccine Contract Manufacturing Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 Belgium Vaccine Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for vaccines globally |
4.2.2 Growing focus on outsourcing vaccine manufacturing to specialized contract manufacturers |
4.2.3 Advancements in technology and manufacturing processes in the pharmaceutical industry |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and quality standards for vaccine manufacturing |
4.3.2 High costs associated with setting up and maintaining vaccine manufacturing facilities |
4.3.3 Limited availability of skilled workforce in the vaccine manufacturing sector |
5 Belgium Vaccine Contract Manufacturing Market Trends |
6 Belgium Vaccine Contract Manufacturing Market, By Types |
6.1 Belgium Vaccine Contract Manufacturing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Belgium Vaccine Contract Manufacturing Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Belgium Vaccine Contract Manufacturing Market Revenues & Volume, By Fill-Finish, 2022 - 2032F |
6.1.4 Belgium Vaccine Contract Manufacturing Market Revenues & Volume, By Bulk Product, 2022 - 2032F |
6.2 Belgium Vaccine Contract Manufacturing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Belgium Vaccine Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2022 - 2032F |
6.2.3 Belgium Vaccine Contract Manufacturing Market Revenues & Volume, By Biotech Companies, 2022 - 2032F |
6.2.4 Belgium Vaccine Contract Manufacturing Market Revenues & Volume, By Others, 2022 - 2032F |
7 Belgium Vaccine Contract Manufacturing Market Import-Export Trade Statistics |
7.1 Belgium Vaccine Contract Manufacturing Market Export to Major Countries |
7.2 Belgium Vaccine Contract Manufacturing Market Imports from Major Countries |
8 Belgium Vaccine Contract Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in research and development investments in vaccine technology |
8.2 Number of strategic partnerships and collaborations between vaccine developers and contract manufacturers |
8.3 Percentage growth in the adoption of advanced manufacturing technologies in vaccine production |
8.4 Average time-to-market for new vaccines developed and manufactured in Belgium |
8.5 Number of new vaccine development projects outsourced to contract manufacturers in Belgium |
9 Belgium Vaccine Contract Manufacturing Market - Opportunity Assessment |
9.1 Belgium Vaccine Contract Manufacturing Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Belgium Vaccine Contract Manufacturing Market Opportunity Assessment, By Application, 2022 & 2032F |
10 Belgium Vaccine Contract Manufacturing Market - Competitive Landscape |
10.1 Belgium Vaccine Contract Manufacturing Market Revenue Share, By Companies, 2025 |
10.2 Belgium Vaccine Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here